fullerene c60 has been researched along with buthionine sulfoximine in 2 studies
| Studies (fullerene c60) | Trials (fullerene c60) | Recent Studies (post-2010) (fullerene c60) | Studies (buthionine sulfoximine) | Trials (buthionine sulfoximine) | Recent Studies (post-2010) (buthionine sulfoximine) |
|---|---|---|---|---|---|
| 3,806 | 5 | 2,170 | 2,460 | 8 | 408 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Harper, SL; Tanguay, RL; Usenko, CY | 1 |
| Igisu, H; Sumizawa, T | 1 |
2 other study(ies) available for fullerene c60 and buthionine sulfoximine
| Article | Year |
|---|---|
Fullerene C60 exposure elicits an oxidative stress response in embryonic zebrafish.
Topics: Acetylcysteine; Animals; Buthionine Sulfoximine; Carrier Proteins; Embryo, Nonmammalian; Ferritins; Fullerenes; Gene Expression Regulation; Glutamate-Cysteine Ligase; Glutathione Transferase; HSP70 Heat-Shock Proteins; Hydrogen Peroxide; Light; Maleates; Microarray Analysis; Models, Animal; Oxidative Stress; Pericardial Effusion; Time Factors; Zebrafish | 2008 |
Suppression of acrylamide toxicity by carboxyfullerene in human neuroblastoma cells in vitro.
Topics: Acrylamide; Antineoplastic Agents; Buthionine Sulfoximine; Carboxylic Acids; Caspase 3; Cell Line, Tumor; Cell Survival; Cytoprotection; Dose-Response Relationship, Drug; Fullerenes; G1 Phase; Glutathione; Humans; L-Lactate Dehydrogenase; Nanoparticles; Neuroblastoma; Neurons; Particle Size | 2009 |